Clinical outcomes of transarterial chemoembolization combined with durvalumab for advanced and metastatic biliary tract cancer

Background This study aimed to evaluate the safety and efficacy of TACE combined with durvalumab for treating advanced and metastatic BTC. Research design and methods: Data were collected retrospectively from a single center. The TACE procedures were performed 1 to 19 times, with repetitions occurri...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yuefeng Hu, Jian Wei, Xuedong Sun, Guang Chen, Tianhao Su, Zeran Yang, Xu Lu, Long Jin
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2025-12-01
coleção:	Future Science OA
Assuntos:	Biliary tract cancer immune checkpoint inhibitors transarterial chemoembolization durvalumab Immunotherapy
Acesso em linha:	https://www.tandfonline.com/doi/10.1080/20565623.2025.2526947
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!